MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Fresenius Medical Care AG & Co KGaA

Slēgts

25.65 3.93

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

24.68

Max

25.95

Galvenie mērījumi

By Trading Economics

Ienākumi

-146M

119M

Pārdošana

325M

5.1B

P/E

Sektora vidējais

24.9

63.778

EPS

0.455

Dividenžu ienesīgums

2.58

Peļņas marža

2.338

Darbinieki

111,513

EBITDA

-565M

281M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+10.95% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

2.58%

2.39%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

933M

15B

Iepriekšējā atvēršanas cena

21.72

Iepriekšējā slēgšanas cena

25.65

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

Fresenius Medical Care AG & Co KGaA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 21. marts 08:19 UTC

Tirgus saruna

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

2025. g. 25. febr. 10:27 UTC

Tirgus saruna
Peļņas

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

2024. g. 15. jūl. 08:17 UTC

Tirgus saruna

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

2024. g. 3. maijs 08:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Salīdzinājums

Cenas izmaiņa

Fresenius Medical Care AG & Co KGaA Prognoze

Cenas mērķis

By TipRanks

10.95% augšup

Prognoze 12 mēnešiem

Vidējais 27.45 USD  10.95%

Augstākais 28.9 USD

Zemākais 26 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Fresenius Medical Care AG & Co KGaA — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

5 ratings

2

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

24.68 / 24.87Atbalsts un pretestība

Īstermiņā

Neutral Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.